AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. K.
Right arrow Articles by Cho, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. K.
Right arrow Articles by Cho, K.-S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Differentiation of Subtypes of Renal Cell Carcinoma on Helical CT Scans

Jeong Kon Kim1, Tae Kyoung Kim1, Han Jong Ahn2, Chung Soo Kim2, Kyu-Rae Kim3 and Kyoung-Sik Cho1

1 Department of Radiology, Asan Medical Center, University of Ulsan, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, South Korea.
2 Department of Urology, Asan Medical Center, University of Ulsan, Songpa-gu, Seoul, 138-736, South Korea.
3 Department of Pathology, Asan Medical Center, University of Ulsan, Songpa-gu, Seoul, 138-736, South Korea.



View larger version (163K):

[in a new window]
 
Fig. 1A. 50-year-old man with conventional (clear cell) renal carcinoma. Unenhanced CT scan obtained at level of renal hilum shows well-demarcated round mass (arrows) in right kidney. Diameter of mass is 2.5 cm, and attenuation value is 34 H.

 


View larger version (148K):

[in a new window]
 
Fig. 2A. 62-year-old man with conventional (clear cell) renal carcinoma. Unenhanced CT scan obtained at level of superior mesenteric artery shows lobulated mass (arrowheads) with 8-cm diameter and 35-H attenuation value.

 


View larger version (170K):

[in a new window]
 
Fig. 3A. 55-year-old man with papillary renal carcinoma. Unenhanced CT scan obtained at level of renal hilum shows well-demarcated round mass (arrows) with 2.5-cm diameter and 38-H attenuation value in right kidney.

 


View larger version (177K):

[in a new window]
 
Fig. 4A. 58-year-old woman with papillary renal carcinoma. Unenhanced CT scan obtained at level of superior mesenteric artery shows lobulated mass (arrowheads) with 7-cm diameter and 37-H attenuation value. Calcification (arrow) within tumor can be seen.

 


View larger version (161K):

[in a new window]
 
Fig. 5A. 67-year-old man with chromophobe renal carcinoma. Unenhanced CT scan obtained at level of upper pole of right kidney shows lobulated mass (arrowheads) with 8-cm diameter and 37-H attenuation value. Multifocal calcifications (arrows) can be seen within tumor.

 


View larger version (167K):

[in a new window]
 
Fig. 1B. 50-year-old man with conventional (clear cell) renal carcinoma. On contrast-enhanced CT scans obtained at same level as A, attenuation value of lesion (arrows) was measured as 173 H in corticomedullary phase (B) and 76 H in excretory phase (C). Therefore, degree of enhancement was calculated as 139 H in corticomedullary phase and 42 H in excretory phase. This lesion shows heterogeneous enhancement.

 


View larger version (166K):

[in a new window]
 
Fig. 2B. 62-year-old man with conventional (clear cell) renal carcinoma. On contrast-enhanced CT scans, enhancement pattern of lesion (arrowheads) is heterogeneous, and attenuation value was measured as 201 H in corticomedullary phase (degree of enhancement, 166 H) (B) and 128 H in excretory phase (degree of enhancement, 93 H) (C). Perinephric change (arrows) is visible.

 


View larger version (186K):

[in a new window]
 
Fig. 3B. 55-year-old man with papillary renal carcinoma. Contrast-enhanced CT scans obtained at same level as A show homogeneous enhancement of lesion (arrows); attenuation value was measured as 82 H in corticomedullary phase (B) and 75 H in excretory phase (C). Therefore, degree of enhancement was calculated as 44 H in corticomedullary phase and 37 H in excretory phase.

 


View larger version (185K):

[in a new window]
 
Fig. 4B. 58-year-old woman with papillary renal carcinoma. On contrast-enhanced CT scans, enhancement pattern of lesion (arrowheads) is predominantly peripheral, and attenuation value was measured as 94 H and degree of enhancement as 57 H in corticomedullary phase (B) and 71 H and 34 H, respectively, in excretory phase (C).

 


View larger version (163K):

[in a new window]
 
Fig. 5B. 67-year-old man with chromophobe renal carcinoma. On contrast-enhanced CT scans obtained at same level as A, mass (arrowheads) shows homogeneous enhancement that measured 51 H in corticomedullary phase (B) and 33 H in excretory phase (C). Attenuation value was 88 H in corticomedullary phase and 70 H in excretory phase.

 


View larger version (170K):

[in a new window]
 
Fig. 1C. 50-year-old man with conventional (clear cell) renal carcinoma. On contrast-enhanced CT scans obtained at same level as A, attenuation value of lesion (arrows) was measured as 173 H in corticomedullary phase (B) and 76 H in excretory phase (C). Therefore, degree of enhancement was calculated as 139 H in corticomedullary phase and 42 H in excretory phase. This lesion shows heterogeneous enhancement.

 


View larger version (166K):

[in a new window]
 
Fig. 2C. 62-year-old man with conventional (clear cell) renal carcinoma. On contrast-enhanced CT scans, enhancement pattern of lesion (arrowheads) is heterogeneous, and attenuation value was measured as 201 H in corticomedullary phase (degree of enhancement, 166 H) (B) and 128 H in excretory phase (degree of enhancement, 93 H) (C). Perinephric change (arrows) is visible.

 


View larger version (188K):

[in a new window]
 
Fig. 3C. 55-year-old man with papillary renal carcinoma. Contrast-enhanced CT scans obtained at same level as A show homogeneous enhancement of lesion (arrows); attenuation value was measured as 82 H in corticomedullary phase (B) and 75 H in excretory phase (C). Therefore, degree of enhancement was calculated as 44 H in corticomedullary phase and 37 H in excretory phase.

 


View larger version (193K):

[in a new window]
 
Fig. 4C. 58-year-old woman with papillary renal carcinoma. On contrast-enhanced CT scans, enhancement pattern of lesion (arrowheads) is predominantly peripheral, and attenuation value was measured as 94 H and degree of enhancement as 57 H in corticomedullary phase (B) and 71 H and 34 H, respectively, in excretory phase (C).

 


View larger version (169K):

[in a new window]
 
Fig. 5C. 67-year-old man with chromophobe renal carcinoma. On contrast-enhanced CT scans obtained at same level as A, mass (arrowheads) shows homogeneous enhancement that measured 51 H in corticomedullary phase (B) and 33 H in excretory phase (C). Attenuation value was 88 H in corticomedullary phase and 70 H in excretory phase.

 


View larger version (15K):

[in a new window]
 
Fig. 6A. Graphs show receiver operating characteristics curves for degree of enhancement in differentiation of conventional (clear cell) renal carcinoma from nonconventional renal carcinomas (i.e., papillary, chromophobe, and collecting duct). In corticomedullary phase, area under curve (Az value) is 0.833 (95% confidence interval [CI]: 0.702-0.923).

 


View larger version (16K):

[in a new window]
 
Fig. 6B. Graphs show receiver operating characteristics curves for degree of enhancement in differentiation of conventional (clear cell) renal carcinoma from nonconventional renal carcinomas (i.e., papillary, chromophobe, and collecting duct). In excretory phase, Az value is 0.905 (95% CI: 0.825-0.956).

 


View larger version (167K):

[in a new window]
 
Fig. 7A. 64-year-old man with collecting duct renal carcinoma. Unenhanced CT scan obtained at level of upper pole of right kidney shows lobulated mass (arrowheads) with 12-cm diameter and 37-H attenuation value. Perinephric change (arrows) can be seen.

 


View larger version (182K):

[in a new window]
 
Fig. 7B. 64-year-old man with collecting duct renal carcinoma. On contrast-enhanced CT scans obtained at same level as A, mass (arrowheads) shows heterogeneous enhancement with 43-H enhancement in corticomedullary phase (B) and 35-H enhancement in excretory phase (C). Attenuation value was 80 H in corticomedullary phase and 72 H in excretory phase. Perinephric change (arrows) is shown.

 


View larger version (187K):

[in a new window]
 
Fig. 7C. 64-year-old man with collecting duct renal carcinoma. On contrast-enhanced CT scans obtained at same level as A, mass (arrowheads) shows heterogeneous enhancement with 43-H enhancement in corticomedullary phase (B) and 35-H enhancement in excretory phase (C). Attenuation value was 80 H in corticomedullary phase and 72 H in excretory phase. Perinephric change (arrows) is shown.

 


View larger version (194K):

[in a new window]
 
Fig. 7D. 64-year-old man with collecting duct renal carcinoma. CT scan obtained in excretory phase 8 cm above A shows tumor invasion (arrows) of renal vein.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.